SAGE Therapeutics (SAGE)
NASDAQ:SAGE
Holding SAGE?
Track your performance easily

SAGE Therapeutics (SAGE) Financial Statements

882 Followers

SAGE Therapeutics Financial Overview

SAGE Therapeutics's market cap is currently ―. The company's EPS TTM is $-7.413; its P/E ratio is -1.01; SAGE Therapeutics is scheduled to report earnings on November 5, 2024, and the estimated EPS forecast is $-1.55. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 8.65M$ 2.72M$ 2.46M$ 3.29M$ 2.86M
Gross Profit$ 8.65M$ 1.81M$ 2.47M$ 3.29M$ 2.86M
EBIT$ -102.85M$ -178.25M$ -159.91M$ -155.66M$ -153.94M
EBITDA$ -102.54M$ -177.92M$ -159.58M$ -155.34M$ -153.67M
Net Income Common Stockholders$ -101.45M$ -201.63M$ -160.32M$ -146.83M$ -147.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 646.79M$ 876.05M$ 1.00B$ 1.13B$ 1.27B
Total Assets$ 697.11M$ 949.66M$ 1.08B$ 1.22B$ 1.35B
Total Debt$ 1.41M$ 6.97M$ 8.73M$ 10.45M$ 12.13M
Net Debt$ -645.38M$ -869.09M$ -993.89M$ -1.12B$ -1.26B
Total Liabilities$ 69.04M$ 133.00M$ 97.91M$ 87.56M$ 1.38B
Stockholders Equity$ 628.06M$ 816.66M$ 984.38M$ 1.13B$ 1.28B
Cash Flow-
Free Cash Flow$ -80.44M$ -136.19M$ -131.63M$ -153.91M$ -127.24M
Operating Cash Flow$ -80.44M$ -135.87M$ -131.52M$ -153.68M$ -126.95M
Investing Cash Flow$ -386.00K$ 160.39M$ 45.59M$ 194.87M$ 89.78M
Financing Cash Flow$ 8.07M$ 2.77M$ 847.00K$ 2.67M$ 29.00K
Currency in USD

SAGE Therapeutics Earnings and Revenue History

SAGE Therapeutics Debt to Assets

SAGE Therapeutics Cash Flow

SAGE Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis